Red Arrow Therapeutics

Minato, Japan

Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

Sep 2024

Series A

Alternative Medicine Biotechnology Product Research

Top Investors

UTEC - The University of Tokyo Edge Capital PartnersBeyond Next VenturesCure VenturesThird Rock VenturesSkyDeck Berkeley

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Red Arrow Therapeutics

Who are Red Arrow Therapeutics's investors?

Red Arrow Therapeutics's investors include UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures, Cure Ventures, Third Rock Ventures, SkyDeck Berkeley.

Where is Red Arrow Therapeutics headquartered?

Red Arrow Therapeutics is headquartered in Minato, Japan.

What does Red Arrow Therapeutics do?

Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

What stage is Red Arrow Therapeutics at?

Red Arrow Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 18, 2024.

MLA

"Red Arrow Therapeutics — Funding & Investors." VCBacked, September 18, 2024, https://www.vcbacked.co/company/red-arrow-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Red Arrow Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/red-arrow-therapeutics

Wikipedia (cite web)

{{cite web |title=Red Arrow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/red-arrow-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 18, 2024.